AU2002329784A1 - Molecules for disease detection and treatment - Google Patents

Molecules for disease detection and treatment

Info

Publication number
AU2002329784A1
AU2002329784A1 AU2002329784A AU2002329784A AU2002329784A1 AU 2002329784 A1 AU2002329784 A1 AU 2002329784A1 AU 2002329784 A AU2002329784 A AU 2002329784A AU 2002329784 A AU2002329784 A AU 2002329784A AU 2002329784 A1 AU2002329784 A1 AU 2002329784A1
Authority
AU
Australia
Prior art keywords
molecules
treatment
disease detection
disease
detection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002329784A
Inventor
Janice K. Au-Young
Ines Barroso
Mariah R. Baughn
Shanya D. Becha
Neil Burford
Narinder K. Chawla
Brendan M. Duggan
Vicki S. Elliott
Brooke M. Emerling
Ian J. Forsythe
Ameena R. Gandhi
Kimberly J. Gietzen
Ann E. Gorvad
Jennifer A. Griffin
April J.A. Hafalia
Craig H. Ison
Liam Kearney
Ernestine A. Lee
Sally Lee
Soo Yeun Lee
Patricia M. Lehr-Mason
Erika A. Lindquist
Dyung Aina M. Lu
Thomas W. Richardson
Anita Swarnakar
Y. Tom Tang
Kavitha Thangavelu
Uyen K. Tran
Bridget A. Warren
Yuming Xu
Monique G. Yao
Henry Yue
Yeganeh Zebarjadian
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Incyte Corp
Original Assignee
Incyte Genomics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incyte Genomics Inc filed Critical Incyte Genomics Inc
Publication of AU2002329784A1 publication Critical patent/AU2002329784A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
AU2002329784A 2001-08-17 2002-08-16 Molecules for disease detection and treatment Abandoned AU2002329784A1 (en)

Applications Claiming Priority (13)

Application Number Priority Date Filing Date Title
US31311501P 2001-08-17 2001-08-17
US60/313,115 2001-08-17
US31678501P 2001-08-31 2001-08-31
US60/316,785 2001-08-31
US32340701P 2001-09-17 2001-09-17
US60/323,407 2001-09-17
US32602201P 2001-09-28 2001-09-28
US60/326,022 2001-09-28
US37070702P 2002-04-05 2002-04-05
US60/370,707 2002-04-05
US37986202P 2002-05-10 2002-05-10
US60/379,862 2002-05-10
PCT/US2002/026411 WO2003016497A2 (en) 2001-08-17 2002-08-16 Molecules for disease detection and treatment

Publications (1)

Publication Number Publication Date
AU2002329784A1 true AU2002329784A1 (en) 2003-03-03

Family

ID=27559694

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002329784A Abandoned AU2002329784A1 (en) 2001-08-17 2002-08-16 Molecules for disease detection and treatment

Country Status (2)

Country Link
AU (1) AU2002329784A1 (en)
WO (1) WO2003016497A2 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7351551B2 (en) * 2001-12-07 2008-04-01 Nissui Pharmaceutical Co., Ltd. Adipocyte differentiation-associated gene and protein
US7442685B2 (en) 2003-06-13 2008-10-28 The University Of North Carolina At Chapel Hill DOT1 histone methyltransferases as a target for identifying therapeutic agents for leukemia
WO2006025832A1 (en) * 2004-08-31 2006-03-09 University Of North Carolina At Chapel Hill Dot1 histone methyltransferases as a target for identifying therapeutic agents for leukemia
WO2007087015A1 (en) 2006-01-20 2007-08-02 The University Of North Carolina At Chapel Hill Diagnostic and therapeutic targets for leukemia
CN103209987B (en) 2010-09-22 2017-06-06 艾丽奥斯生物制药有限公司 Substituted nucleotide analog
EP2794630A4 (en) 2011-12-22 2015-04-01 Alios Biopharma Inc Substituted phosphorothioate nucleotide analogs
CN104321333A (en) 2012-03-21 2015-01-28 沃泰克斯药物股份有限公司 Solid forms of a thiophosphoramidate nucleotide prodrug
NZ630805A (en) 2012-03-22 2016-01-29 Alios Biopharma Inc Pharmaceutical combinations comprising a thionucleotide analog
US11344121B2 (en) 2016-04-14 2022-05-31 The Texas A&M University System Methods of predicting preeclampsia using biomarkers
WO2022212928A1 (en) * 2021-04-02 2022-10-06 The Regents Of The University Of California Modified viruses and viral particles, methods of making, and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1314371A (en) * 2000-03-17 2001-09-26 上海博德基因开发有限公司 New polypeptide-human retinaldehyde binding proteing 39 and polynucleotide for coding such polypeptide

Also Published As

Publication number Publication date
WO2003016497A2 (en) 2003-02-27
WO2003016497A3 (en) 2003-05-22

Similar Documents

Publication Publication Date Title
AU2002338265A1 (en) Molecules for disease detection and treatment
AU2001255655A1 (en) Treatment analysis systems and methods
AUPP784398A0 (en) Kidney disease detection and treatment
AU2002258388A1 (en) Narc8 programmed cell-death-associated molecules and uses thereof
AU2002220266A1 (en) Methods for the identification and the treatment of cardiovascular disease
AU2002329784A1 (en) Molecules for disease detection and treatment
AU2002318356A1 (en) Protein modification and maintenance molecules
AU2002349268A1 (en) Medicine for preventing and treating bromidrosis
AU2002364890A1 (en) Molecules for disease detection and treatment
AU2001241709A1 (en) Molecules for disease detection and treatment
AU2003205174A1 (en) Molecules for disease detection and treatment
AU2002327945A1 (en) Human delta-n p73 molecules and uses thereof
AU2002347899A1 (en) Molecules for disease detection and treatment
AU2002243539A1 (en) Molecules for disease detection and treatment
GB0115780D0 (en) Therapeutic molecules and uses thereof
AU2002359567A1 (en) Molecules for disease detection and treatment
AU2002248723A1 (en) Molecules for disease detection and treatment
AU2002239543A1 (en) Molecules for disease detection and treatment
AU2002320630A1 (en) Detecting and treating reproductive tract disorders
AU5319400A (en) Molecules for disease detection and treatment
AU2002320026A1 (en) Molecules for disease detection and treatment
AU2003231245A1 (en) Molecules for disease detection and treatment
EP1390410A4 (en) Molecules for disease detection and treatment
AU2002238070A1 (en) Molecules for disease detection and treatment
AU2002249910A1 (en) Molecules for disease detection and treatment

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase